<p>Evernest Financial Advisors LLC 在最近向证券交易委员会提交的 13F 文件中披露，其在礼来的股份（NYSE:LLY - 免费报告）中持股比例在第一季度增加了 8.1%。该公司在本季度额外购买了 360 股后，持有该公司 4,779 股股票。礼来公司占 Evernest Financial Advisors LLC 投资组合的 1.4%，是其第 19 大持仓。截至最近向证券交易委员会提交的文件，Evernest Financial Advisors LLC 在礼来公司的持股价值为 3,947,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>诺和诺德股票下跌——但底部终于到来了吗？</li>
</ul>
<p>其他一些机构投资者和对冲基金最近也调整了对 LLY 的持股。WestEnd Advisors LLC 在第一季度将其在礼来公司的持仓增加了 210.0%。WestEnd Advisors LLC 现在拥有 31 股该公司的股票，价值 26,000 美元，此前在上个季度额外购买了 21 股。Citizens National Bank Trust Department 在第一季度将其在礼来公司的股份增加了 180.0%。Citizens National Bank Trust Department 现在拥有 42 股该公司的股票，价值 35,000 美元，此前在此期间额外购买了 27 股。Financial Gravity Asset Management Inc.在第一季度购买了礼来公司的新头寸，价值 40,000 美元。Mascagni Wealth Management Inc.在第四季度购买了礼来公司的新股份，价值约 43,000 美元。最后，O Brien Wealth Partners LLC 在第一季度将其在礼来公司的持仓增加了 25.5%。O Brien Wealth Partners LLC 现在拥有 59 股该公司的股票，价值 49,000 美元，此前在上个季度额外购买了 12 股。82.53% 的股票由机构投资者持有。</p>
<h2>礼来公司股票下跌 2.6%</h2>
<p>NYSE:LLY 的股票在周四开盘价为 746.17 美元。该公司的 50 日简单移动平均为 777.97 美元，200 日简单移动平均为 800.20 美元。该公司的速动比率为 1.06，流动比率为 1.37，债务与股本比率为 2.18。该公司的市值为 7071.7 亿美元，市盈率为 60.71，市盈增长比率为 1.09，贝塔值为 0.44。礼来公司的 12 个月低点为 677.09 美元，12 个月高点为 972.53 美元。</p>
<h2>礼来公司宣布分红</h2>
<ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
<p>该公司最近还宣布了一项季度分红，将于 9 月 10 日（星期三）支付。8 月 15 日（星期五）登记在册的股东将获得 1.50 美元的分红。除息日期为 8 月 15 日（星期五）。这代表着年化分红为 6.00 美元，分红收益率为 0.8%。礼来公司的派息比率为 48.82%。</p>
<h2>华尔街分析师观点</h2>
<p>几位分析师最近对 LLY 股票发表了看法。摩根士丹利在 7 月 10 日的报告中重申了 “增持” 评级，并将礼来公司的目标价从 1,133.00 美元上调至 1,135.00 美元。汇丰银行将礼来公司的评级从 “买入” 下调至 “减持”，并在 4 月 28 日的报告中将其目标价从 1,150.00 美元下调至 700.00 美元。古根海姆在 7 月 11 日的报告中将礼来公司的目标价从 936.00 美元上调至 942.00 美元，并给予该股票 “买入” 评级。Cantor Fitzgerald 在 4 月 22 日的研究报告中开始覆盖礼来公司的股票，设定了 “增持” 评级和 975.00 美元的目标价。最后，Erste Group Bank 在 6 月 5 日的研究报告中将礼来公司的评级从 “买入” 下调至 “持有”。一位分析师对该股票给予了卖出评级，三位分析师给予了持有评级，十七位分析师给予了买入评级。根据 MarketBeat 的数据，礼来公司的平均评级为 “适度买入”，平均目标价为 1,012.56 美元。</p>
<ul>
<li>高盛在其看涨的标准普尔 500 展望中重点关注这 3 只股票</li>
</ul>
<p><strong>获取我们对礼来公司的最新分析</strong></p>
<h2>礼来公司简介</h2>
<p>（免费报告）</p>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票超过礼来公司</li>
<li>如何交易便士股票：逐步指南</li>
<li>买入下跌？这些盈利失误提供长期上涨潜力</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>RSI 股票在第二季度暴涨 22%——PENN 会跟上这种势头吗？</li>
<li>如何计算退休收入：MarketBeat 的计算器</li>
<li>DigitalOcean 的专注如何推动爆炸性增长</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在考虑投资礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
<p>虽然礼来公司的分析师评级为适度买入，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Evernest Financial Advisors LLC 在第一季度将其在礼来公司（NYSE: LLY）的持股增加了 8.1%，额外购买了 360 股，总持股达到 4,779 股，价值约为 395 万美元。礼来在 Evernest 的投资组合中占比 1.4%。该股票目前下跌 2.6%，交易价格为 746.17 美元，市值为 7071.7 亿美元。分析师的评级不一，平均目标价为 1,012.56 美元，显示出 “适度买入” 的情绪</p>

<p>Evernest Financial Advisors LLC raised its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 8.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,779 shares of the company's stock after buying an additional 360 shares during the quarter. Eli Lilly and Company comprises 1.4% of Evernest Financial Advisors LLC's portfolio, making the stock its 19th biggest position. Evernest Financial Advisors LLC's holdings in Eli Lilly and Company were worth $3,947,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Evernest Financial Advisors LLC 在最近向证券交易委员会提交的 13F 文件中披露，其在礼来的股份（NYSE:LLY - 免费报告）中持股比例在第一季度增加了 8.1%。该公司在本季度额外购买了 360 股后，持有该公司 4,779 股股票。礼来公司占 Evernest Financial Advisors LLC 投资组合的 1.4%，是其第 19 大持仓。截至最近向证券交易委员会提交的文件，Evernest Financial Advisors LLC 在礼来公司的持股价值为 3,947,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Novo Nordisk Stock Sinks—But Is a Bottom Finally In?</li>
</ul>
<div class="lb-trans"><ul>
<li>诺和诺德股票下跌——但底部终于到来了吗？</li>
</ul>
</div><p>A number of other institutional investors and hedge funds also recently modified their holdings of LLY. WestEnd Advisors LLC boosted its position in Eli Lilly and Company by 210.0% during the 1st quarter. WestEnd Advisors LLC now owns 31 shares of the company's stock worth $26,000 after acquiring an additional 21 shares during the last quarter. Citizens National Bank Trust Department boosted its stake in shares of Eli Lilly and Company by 180.0% during the 1st quarter. Citizens National Bank Trust Department now owns 42 shares of the company's stock worth $35,000 after acquiring an additional 27 shares during the period. Financial Gravity Asset Management Inc. bought a new position in Eli Lilly and Company during the first quarter worth $40,000. Mascagni Wealth Management Inc. bought a new stake in shares of Eli Lilly and Company during the 4th quarter worth about $43,000. Finally, O Brien Wealth Partners LLC lifted its position in Eli Lilly and Company by 25.5% during the first quarter. O Brien Wealth Partners LLC now owns 59 shares of the company's stock worth $49,000 after acquiring an additional 12 shares during the last quarter. 82.53% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些机构投资者和对冲基金最近也调整了对 LLY 的持股。WestEnd Advisors LLC 在第一季度将其在礼来公司的持仓增加了 210.0%。WestEnd Advisors LLC 现在拥有 31 股该公司的股票，价值 26,000 美元，此前在上个季度额外购买了 21 股。Citizens National Bank Trust Department 在第一季度将其在礼来公司的股份增加了 180.0%。Citizens National Bank Trust Department 现在拥有 42 股该公司的股票，价值 35,000 美元，此前在此期间额外购买了 27 股。Financial Gravity Asset Management Inc.在第一季度购买了礼来公司的新头寸，价值 40,000 美元。Mascagni Wealth Management Inc.在第四季度购买了礼来公司的新股份，价值约 43,000 美元。最后，O Brien Wealth Partners LLC 在第一季度将其在礼来公司的持仓增加了 25.5%。O Brien Wealth Partners LLC 现在拥有 59 股该公司的股票，价值 49,000 美元，此前在上个季度额外购买了 12 股。82.53% 的股票由机构投资者持有。</p>
</div><h2>Eli Lilly and Company Stock Down 2.6%</h2>
<div class="lb-trans"><h2>礼来公司股票下跌 2.6%</h2>
</div><p>Shares of NYSE:LLY opened at $746.17 on Thursday. The business has a fifty day simple moving average of $777.97 and a 200 day simple moving average of $800.20. The company has a quick ratio of 1.06, a current ratio of 1.37 and a debt-to-equity ratio of 2.18. The firm has a market cap of $707.17 billion, a P/E ratio of 60.71, a P/E/G ratio of 1.09 and a beta of 0.44. Eli Lilly and Company has a 12-month low of $677.09 and a 12-month high of $972.53.</p>
<div class="lb-trans"><p>NYSE:LLY 的股票在周四开盘价为 746.17 美元。该公司的 50 日简单移动平均为 777.97 美元，200 日简单移动平均为 800.20 美元。该公司的速动比率为 1.06，流动比率为 1.37，债务与股本比率为 2.18。该公司的市值为 7071.7 亿美元，市盈率为 60.71，市盈增长比率为 1.09，贝塔值为 0.44。礼来公司的 12 个月低点为 677.09 美元，12 个月高点为 972.53 美元。</p>
</div><h2>Eli Lilly and Company Announces Dividend</h2>
<div class="lb-trans"><h2>礼来公司宣布分红</h2>
</div><ul>
<li>Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 10th. Stockholders of record on Friday, August 15th will be given a $1.50 dividend. The ex-dividend date is Friday, August 15th. This represents a $6.00 dividend on an annualized basis and a dividend yield of 0.8%. Eli Lilly and Company's payout ratio is 48.82%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 9 月 10 日（星期三）支付。8 月 15 日（星期五）登记在册的股东将获得 1.50 美元的分红。除息日期为 8 月 15 日（星期五）。这代表着年化分红为 6.00 美元，分红收益率为 0.8%。礼来公司的派息比率为 48.82%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several analysts recently weighed in on LLY shares. Morgan Stanley reissued an &#34;overweight&#34; rating and set a $1,135.00 price target (up from $1,133.00) on shares of Eli Lilly and Company in a report on Thursday, July 10th. HSBC lowered Eli Lilly and Company from a &#34;buy&#34; rating to a &#34;reduce&#34; rating and reduced their target price for the stock from $1,150.00 to $700.00 in a report on Monday, April 28th. Guggenheim upped their price target on shares of Eli Lilly and Company from $936.00 to $942.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, July 11th. Cantor Fitzgerald began coverage on shares of Eli Lilly and Company in a research report on Tuesday, April 22nd. They set an &#34;overweight&#34; rating and a $975.00 price objective for the company. Finally, Erste Group Bank lowered Eli Lilly and Company from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, June 5th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat, Eli Lilly and Company has an average rating of &#34;Moderate Buy&#34; and an average target price of $1,012.56.</p>
<div class="lb-trans"><p>几位分析师最近对 LLY 股票发表了看法。摩根士丹利在 7 月 10 日的报告中重申了 “增持” 评级，并将礼来公司的目标价从 1,133.00 美元上调至 1,135.00 美元。汇丰银行将礼来公司的评级从 “买入” 下调至 “减持”，并在 4 月 28 日的报告中将其目标价从 1,150.00 美元下调至 700.00 美元。古根海姆在 7 月 11 日的报告中将礼来公司的目标价从 936.00 美元上调至 942.00 美元，并给予该股票 “买入” 评级。Cantor Fitzgerald 在 4 月 22 日的研究报告中开始覆盖礼来公司的股票，设定了 “增持” 评级和 975.00 美元的目标价。最后，Erste Group Bank 在 6 月 5 日的研究报告中将礼来公司的评级从 “买入” 下调至 “持有”。一位分析师对该股票给予了卖出评级，三位分析师给予了持有评级，十七位分析师给予了买入评级。根据 MarketBeat 的数据，礼来公司的平均评级为 “适度买入”，平均目标价为 1,012.56 美元。</p>
</div><ul>
<li>Goldman Spotlights These 3 Stocks in Its Bullish S&amp;P 500 Outlook</li>
</ul>
<div class="lb-trans"><ul>
<li>高盛在其看涨的标准普尔 500 展望中重点关注这 3 只股票</li>
</ul>
</div><p><strong>Get Our Latest Analysis on Eli Lilly and Company</strong></p>
<div class="lb-trans"><p><strong>获取我们对礼来公司的最新分析</strong></p>
</div><h2>Eli Lilly and Company Profile</h2>
<div class="lb-trans"><h2>礼来公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>How to trade penny stocks: A step-by-step guide</li>
<li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li>
<li>What Investors Need to Know About Upcoming IPOs</li>
<li>RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum?</li>
<li>How to Calculate Retirement Income: MarketBeat’s Calculator</li>
<li>How DigitalOcean's Focus Is Fueling Explosive Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过礼来公司</li>
<li>如何交易便士股票：逐步指南</li>
<li>买入下跌？这些盈利失误提供长期上涨潜力</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>RSI 股票在第二季度暴涨 22%——PENN 会跟上这种势头吗？</li>
<li>如何计算退休收入：MarketBeat 的计算器</li>
<li>DigitalOcean 的专注如何推动爆炸性增长</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司的分析师评级为适度买入，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Evernest Financial Advisors LLC 购入了礼来公司（NYSE:LLY）的 360 股股票